Skip to main content

Advertisement

Log in

PON1 55 and 192 Gene Polymorphisms in Type 2 Diabetes Mellitus Patients in a Turkish Population

  • Published:
Biochemical Genetics Aims and scope Submit manuscript

Abstract

Diabetes mellitus is a multifactorial metabolic disease, caused by the complete or relative absence of insulin hormone, which results in the deterioration of carbohydrate, protein, and lipid metabolism. The PON1 55 and 192 polymorphisms have been reported to be associated with type 2 diabetes and its complications. In this study, the involvement of the PON1 55 and 192 polymorphisms and paraoxonase enzyme activity in diabetic complications was assessed. The MM and QQ genotypes were the most frequent in complications of type 2 diabetes in both of the polymorphisms. PON enzyme activity was lower in the type 2 diabetes group with respect to the control group. Regarding both genotypes and enzyme activity, correlations were found between the PON1 55 and 192 genotypes and diabetic complications. This study thus helps to outline a genotype–phenotype relation for the PON1 gene in a Turkish population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN (1995) Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 15:1812–1818

    CAS  PubMed  Google Scholar 

  • Adkins S, Gan KN, Mody M, La Du BN (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 52:598–608

    CAS  PubMed  Google Scholar 

  • Agrawal S, Tripathi G, Prajnya R, Sinha N, Gilmour A, Bush L, Mastana S (2009) Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians. Indian J Med Sci 63:335–344

    Article  CAS  PubMed  Google Scholar 

  • Aynacioglu AS, Kepekci Y (2000) The human paraoxonase Gln-Argl92 (Q/R) polymorphism in turkish patients with coronary artery disease. Int J Cardiol 74:33–37

    Article  CAS  PubMed  Google Scholar 

  • Bilge I, Sirin A, Agachan B, Emre S, Sadikoglu B, Yilmaz H, Sucu A, Isbir T (2007) Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children? Cell Biochem Funct 25:159–165

    Article  CAS  PubMed  Google Scholar 

  • Demirdogen BC, Demirkaya S, Türkanoglu A, Bek S, Arinc E, Adali O (2009) Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population. Cell Biochem Funct 27:558–567

    Article  PubMed  Google Scholar 

  • Expert Committee (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26:S5–S20

    Article  Google Scholar 

  • Furlong CE, Richter RJ, Seidel SL, Motulsky AG (1988) Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyriphos oxon and paraoxon. Am J Human Genet 43:230–238

    CAS  Google Scholar 

  • Gluba A, Pietrucha T, Banach M, Piotrowski G, Rysz J (2010) The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study. Angiology 61:157–165

    Article  CAS  PubMed  Google Scholar 

  • Groop LC (1997) The molecular genetics of non-insulin-dependent diabetes mellitus. J Intern Med 241:95–101

    Article  CAS  PubMed  Google Scholar 

  • Hu Y, Tian H, Liu R (2003) Gln-Arg192 polymorphism of paraoxonase 1 is associated with carotid intima-media thickness in patients of type 2 diabetes mellitus of Chinese. Diabetes Res Clin Pract 61:21–27

    Article  CAS  PubMed  Google Scholar 

  • Kaman D, Ilhan N, Metin K, Akbulut M, Ustündag B (2009) A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease. Cell Biochem Funct 27:88–92

    Article  CAS  PubMed  Google Scholar 

  • Kao YL, Donaghue K, Chan A, Knight J, Silink M (1998) A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM. J Clin Endocrinol Metab 83:2589–2592

    Article  CAS  PubMed  Google Scholar 

  • Kopprasch S, Pietzsch J, Kuhlisch E, Graessler J (2003) Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus. J Clin Endocrinol Metab 88:1711–1716

    Article  CAS  PubMed  Google Scholar 

  • Mackness B, Durrington PN, Abuashia B, Boulton AJ, Mackness MI (2000) Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci (Lond) 98:355–363

    Article  CAS  Google Scholar 

  • Mackness B, Durrington PN, Boulton AJ, Hine D, Mackness MI (2002) Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. Eur J Clin Invest 32:259–264

    Article  CAS  PubMed  Google Scholar 

  • Motti C, Dessì M, Gnasso A, Irace C, Indigeno P, Angelucci CB, Bernardini S, Fucci G, Federici G, Cortese C (2001) A multiplex PCR-based DNA assay for the detection of paraoxonase gene cluster polymorphisms. Atherosclerosis 158:35–40

    Article  CAS  PubMed  Google Scholar 

  • Nevin DN, Zambon A, Furlong CE, Richter RJ, Humbert R, Hokanson JE, Brunzell JD (1996) Paraoxonase genotypes, lipoprotein lipase activity, and HDL. Arterioscler Thromb Vasc Biol 16:1243–1249

    CAS  PubMed  Google Scholar 

  • Ozkök E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I (2008) Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients. Med Sci Monit 14(10):CR536–CR542

    PubMed  Google Scholar 

  • Potluri R, Purmah Y, Dowlut M, Sewpaul N, Lavu D (2009) Microvascular diabetic complications are more prevalent in India compared to Mauritius and the UK due to poorer diabetic control. Diabetes Res Clin Pract 86:e39–e40

    Article  PubMed  Google Scholar 

  • Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN (1996) The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33:498–507

    Article  CAS  PubMed  Google Scholar 

  • Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, Kumon Y, Hashimoto K (2004) Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 53:297–302

    Article  CAS  PubMed  Google Scholar 

  • Ueno T, Shimazaki E, Matsumoto T, Watanabe H, Tsunemi A, Takahashi Y, Mori M, Hamano R, Fujioka T, Soma M, Matsumoto K, Kanmatsuse K (2003) Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population. Med Sci Monit 9:CR208–CR212

    CAS  PubMed  Google Scholar 

  • Zama T, Murata M, Matsubara Y, Kawano K, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y (1997) A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol 17:3565–3569

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Ali Ergun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ergun, M.A., Yurtcu, E., Demirci, H. et al. PON1 55 and 192 Gene Polymorphisms in Type 2 Diabetes Mellitus Patients in a Turkish Population. Biochem Genet 49, 1–8 (2011). https://doi.org/10.1007/s10528-010-9376-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10528-010-9376-6

Keywords

Navigation